Beta Bionics, Inc.(BBNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BBNX Beta Bionics, Inc.

Pre-Market Trading 04-09 07:10:30 EDT

9.71

-0.73

-6.99%

High11.14	Low9.54	Vol407.15K
Open11.14	D1 Closing10.44	Amplitude15.33%
Mkt Cap420.92M	Tradable Cap383.98M	Total Shares43.35M
T/O4.07M	T/O Rate1.03%	Tradable Shares39.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":9.71,"timestamp":1744142400000,"preClose":10.44,"halted":0,"volume":407151,"delay":0,"floatShares":39544758,"shares":43348840,"eps":-8.602584,"marketStatus":"Pre-Market Trading","change":-0.73,"latestTime":"04-09 07:10:30 EDT","open":11.14,"high":11.14,"low":9.54,"amount":4074454.1088810004,"amplitude":0.153257,"askPrice":10.24,"askSize":100,"bidPrice":8.48,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-8.602584,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1744205400000},"marketStatusCode":1,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":9.71,"postHourTrading":{"tag":"盘后","latestPrice":9.71,"preClose":9.71,"latestTime":"19:34 EDT","volume":175,"amount":1706.3,"timestamp":1744155263306},"volumeRatio":0.680580768386096},"requestUrl":"/m/hq/s/BBNX","defaultTab":"news","newsList":[{"id":"2524208041","title":"Beta Bionics, Inc. (BBNX) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2524208041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524208041?lang=en_us&edition=full_marsco","pubTime":"2025-04-04 19:16","pubTimestamp":1743765373,"startTime":"0","endTime":"0","summary":"In a report released today, Mathew Blackman from Stifel Nicolaus maintained a Buy rating on Beta Bionics, Inc. (BBNX – Research Report), with a pri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/beta-bionics-inc-bbnx-receives-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/beta-bionics-inc-bbnx-receives-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","SF","BK4127","BBNX"],"gpt_icon":0},{"id":"1143484942","title":"Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration","url":"https://stock-news.laohu8.com/highlight/detail?id=1143484942","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143484942?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 00:28","pubTimestamp":1743438507,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics, Inc.  are soaring 5.21% in intraday trading on Monday, following a positive analyst report from Bank of America Securities. Analyst Travis Steed reiterated a Buy rating on the stock, signaling continued confidence in the company's growth prospects.Beta Bionics, known for its innovative medical technologies, has been gaining attention from investors and analysts alike. The company's strategic expansion plans and potential market opportunities appear to be driving the optim","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"1100546963","title":"Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration","url":"https://stock-news.laohu8.com/highlight/detail?id=1100546963","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100546963?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 00:28","pubTimestamp":1743438507,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics, Inc.  are soaring 5.21% in intraday trading on Monday, following a bullish analyst report from Bank of America Securities. The stock's significant uptick comes after analyst Travis Steed reiterated a Buy rating on BBNX, highlighting the company as an undervalued growth opportunity.In the report released early Monday, Steed emphasized Beta Bionics' strategic expansion plans as a key factor in his positive outlook. While specific details of the report were not immediately a","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Beta Bionics (BBNX) Soars 5.21% Following Bank of America's Buy Rating Reiteration","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["BBNX"],"gpt_icon":0},{"id":"2523910757","title":"Beta Bionics, Inc.: Undervalued Growth Opportunity with Strategic Expansion Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2523910757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523910757?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:15","pubTimestamp":1743419733,"startTime":"0","endTime":"0","summary":"In a report released today, Travis Steed from Bank of America Securities reiterated a Buy rating on Beta Bionics, Inc. (BBNX – Research Report), wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/beta-bionics-inc-undervalued-growth-opportunity-with-strategic-expansion-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/beta-bionics-inc-undervalued-growth-opportunity-with-strategic-expansion-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1496350171.SGD","LU2129689431.USD","LU0321505439.SGD","LU1363072403.SGD","LU1718418525.SGD","LU0256863902.USD","LU0683600562.USD","LU0640476718.USD","LU1280957306.USD","LU1894683264.USD","LU0098860793.USD","LU0130103400.USD","LU0070302665.USD","LU1201861165.SGD","BAC","BK4588","LU0648001328.SGD","LU1162221912.USD","LU1496350502.SGD","LU0256863811.USD","LU0417517546.SGD","LU0314106906.USD","LU0320765489.SGD","BK4559","LU0170899867.USD","LU2129689514.USD","BK4581","LU1894683348.USD","IE00BZ1G4Q59.USD","LU0208291251.USD","LU0310800965.SGD","LU0787776722.HKD","LU1074936037.SGD","BK4585","IE00BLSP4239.USD","IE0002270589.USD","IE00BFXG1179.USD","LU0130102774.USD","LU0868494617.USD","IE00B1BXHZ80.USD","LU0306807586.USD","LU1267930227.SGD","BBNX","LU0320765646.SGD","LU0234572021.USD","LU0128525689.USD","LU1366192091.USD","LU1880398554.USD","LU0052756011.USD","LU2133065610.SGD"],"gpt_icon":0},{"id":"2522853045","title":"Beta Bionics Appoints Gerard Michel as Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2522853045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522853045?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 05:18","pubTimestamp":1743110309,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. ( ($BBNX) ) just unveiled an update. On March 26, 2025, Beta Bionics, Inc. announced the appointment of Gerard Michel as a Class...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beta-bionics-appoints-gerard-michel-as-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beta-bionics-appoints-gerard-michel-as-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2522534031","title":"Press Release: Beta Bionics Announces Board Appointment of Gerard Michel","url":"https://stock-news.laohu8.com/highlight/detail?id=2522534031","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522534031?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 04:45","pubTimestamp":1743108300,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., March 27, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today announced the appointment of Gerard Michel as an independent member of its board of directors, effective March 26, 2025. Mr. Michel is Chief Executive Officer of Delcath Systems , a commercial-stage interventional oncology company.Mr. Michel has over 30 years of experience in the pharmaceutical and medical technology industries across numerous functional areas. Prior to joining Delcath Systems as Chief Executive Officer in 2020, Mr. Michel served as Chief Financial Officer at Vericel Corporation, a biopharmaceutical company. Mr. Michel also served as Chief Financial Officer and Vice President, Corporate Development at Biodel, Inc. from November 2007 to May 2014, and Chief Financial Officer and Vice President of Corporate Development at NPS Pharmaceuticals Inc. from August 2002 to November 2007. Previously, Mr. Michel was a Principal at Booz All","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2522805384","title":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522805384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522805384?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 21:00","pubTimestamp":1742994009,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TriSalus Life Sciences (TLSI – Research Report) and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BBNX","BK4139","TLSI","BK4137","HCSG"],"gpt_icon":0},{"id":"2522061822","title":"Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Alnylam Pharma (ALNY) and Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522061822","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522061822?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 18:40","pubTimestamp":1742985625,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dexcom (DXCM – Research Report), Alnylam Pharma (ALN...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dexcom-dxcm-alnylam-pharma-alny-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dexcom-dxcm-alnylam-pharma-alny-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","LU0354030511.USD","BK4137","BBNX","LU1323610961.USD","ALN","BK4534","LU1923622614.USD","BK4585","IE00BMPRXR70.SGD","BK4504","LU0354030438.USD","BK4082","DXCM","LU2125909593.SGD","LU0266013472.USD","LU2433249047.HKD","BK4588","LU2211815571.USD","LU2125909247.SGD","BK4139","IE00BMPRXN33.USD","HCSG","BK4548","ALNY"],"gpt_icon":0},{"id":"2522915833","title":"Beta Bionics Reports Q4 Loss as Sales Rise; Sets 2025 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2522915833","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522915833?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:50","pubTimestamp":1742935835,"startTime":"0","endTime":"0","summary":"Beta Bionics  reported a Q4 net loss late Tuesday of $2.72 per diluted share.The company did not provide a year-ago per-share figure.Analysts polled by Factset expected a loss of $0.90.Net sales for the quarter ended Dec. 31 were $20.4 million, up from $8.4 million a year earlier.Analysts surveyed by Factset expected $20.2 million.The company set full-year 2025 revenue guidance between $80 million and $85 million.Analysts polled by Factset expect $85.1 million.Beta Bionics completed its initial public offering on Jan. 30, listing on the Nasdaq Global Market.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2522887701","title":"Beta Bionics Q4 2024 GAAP EPS $(2.72) Beats $(2.91) Estimate, Sales $20.400M Beat $20.187M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887701","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887701?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:09","pubTimestamp":1742933340,"startTime":"0","endTime":"0","summary":"Beta Bionics Q4 2024 GAAP EPS $(2.72) Beats $(2.91) Estimate, Sales $20.400M Beat $20.187M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44481372/beta-bionics-q4-2024-gaap-eps-2-72-beats-2-91-estimate-sales-20-400m-beat-20-187m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2522875098","title":"Beta Bionics Inc Outlook 2025 Total Revenue of Approximately $80 Mln to $85 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2522875098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522875098?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:02","pubTimestamp":1742932921,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA672JQT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2522757838","title":"Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522757838","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522757838?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:02","pubTimestamp":1742932920,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., March 25, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter and year ended December 31, 2024 and introduced its annual guidance for the year ending December 31, 2025.Fourth Quarter 2024 Financial Highlights & Key Metrics. Net sales of $20.4 million, up 145% compared to $8.4 million in the fourth quarter of 2023.Durable Medical Equipment  channel net sales of $18.1 million, up 127% compared to $7.9 million in the fourth quarter of 2023.Pharmacy Benefit Plan  channel net sales of $2.4 million, up 491% compared to $0.4 million in the fourth quarter of 2023.Installed customer base  of 15,298 users, up 564% compared to 2,304 in the fourth quarter of 2023.4,084 new patient starts, up 125% compared to 1,818 new patient starts in the fourth quarter of 2023.70% of new patient starts came from multiple daily injections .Low-teens percentage of new patient starts reim","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beta-bionics-announces-fourth-quarter-200200338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","PBP","BBNX"],"gpt_icon":0},{"id":"2520439968","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520439968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520439968?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 18:00","pubTimestamp":1742464800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Amprius Tech Inc                                4Q      (.11)  4:05 PM. ·Lands' End Inc.                                   4Q       .57   6:45 AM. ·Lennar Corp Class A                              1Q      1.70       AMC","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","LEN","JKS","CDLR","CBUS","MBRX","PAYX","SPRY","SOWG","TELA","CELC","BLRX","THRD","CMC","ALUR","DERM","MLKN","NKE","NKTX","BRAG","FLUX","PL","WOR","MREO","KLC","SLS","ASO","BCAB","BBNX","TITN","GDEV","IFRX","FBRX","COYA","JEF","MGNX","SBS","RLMD","TH","LVTX","OUST","BRNS","LPTX","DRI","CURV","RUM","MNSO","ACRV"],"gpt_icon":1},{"id":"2514053418","title":"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514053418","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514053418?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Feb. 27, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth quarter and full year 2024 financial results after the financial markets close on Tuesday, March 25, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time , to review the company’s fourth quarter and full year 2024 performance.Media and Public Relations: Karen HynesVice President of Marketingmedia@betabionics.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beta-bionics-announce-fourth-quarter-120000112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2514097110","title":"BUZZ-U.S. STOCKS ON THE MOVE-  Eli Lilly, Krispy Kreme, PayPal","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097110","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514097110?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 22:30","pubTimestamp":1740493805,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE- Eli Lilly, Krispy Kreme, PayPalEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL6N3PG0G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNUT","02020","PYPL","HRMY","EVS.SI","CHGG","HD","DOMH","NVD3.UK","KDP","CLF","BBNX","NVDS.UK","ONVO","ZM","NIO.SI","CAKE","NVD2.UK","SNVD.UK","NEM","AU","NVIW.SI","YY","IART","LLY","3NVD.UK","PTLO","CSCO","MTSR","PLNT","CIVI","NTRA","SRE","AS","EVER","BKSY"],"gpt_icon":1},{"id":"2514709525","title":"BUZZ-BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2514709525","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514709525?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 20:42","pubTimestamp":1740487363,"startTime":"0","endTime":"0","summary":"BUZZ-BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating** BofA Global Research starts coverage on insulin device maker Beta Bionics BBNX.O with \"buy\" rating and $25 PT, citing its \"differentiated closed-loop algorithm\" that simplifies insulin-dosing for diabetic patients** PT represents a 21.4% upside to stock's last close** Brokerage believes BBNX will help expand the current $2 billion U.S. insulin pump market, which has only seen 7% penetration growth in seven years** Co's iLet insulin pump's simplicity can help those taking daily insulin injections switch to a simpler way - BofA** Brokerage expects BBNX's revenue to grow by $15 mln in 2025 and $26 mln in 2026** Stock has fallen 12.8% since its Nasdaq debut on 30 Jan  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3N3PG140:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BAC"],"gpt_icon":0},{"id":"2514693772","title":"Beta Bionics initiated with a Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2514693772","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514693772?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 02:21","pubTimestamp":1740421261,"startTime":"0","endTime":"0","summary":"BofA initiated coverage of Beta Bionics (BBNX) with a Buy rating and $25 price target Beta’s iLet insulin pump simplifies insulin-dosing for insuli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2513787567","title":"BUZZ-Wall Street bullish on insulin device maker Beta Bionics after IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2513787567","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513787567?lang=en_us&edition=full_marsco","pubTime":"2025-02-24 23:34","pubTimestamp":1740411293,"startTime":"0","endTime":"0","summary":"BUZZ-Wall Street bullish on insulin device maker Beta Bionics after IPO** Wall Street brokerages start coverage of insulin device maker, Beta Bionics BBNX.O, on a bullish note as IPO research quiet pe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF12B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930227.SGD","LU2133065610.SGD","LU0130518102.USD","LU1162221912.USD","BK4589","BK4588","LU0306806265.USD","LU0640476718.USD","LU0170899867.USD","BK4207","IE0002270589.USD","LU0130103400.USD","BK4559","IE00BLSP4452.SGD","LU0648000940.SGD","IE00B19Z3581.USD","LU0787776722.HKD","LU1074936037.SGD","LU1366192091.USD","LU1718418525.SGD","LU0234572021.USD","LU2129689605.HKD","LU0417517546.SGD","LU1894683264.USD","LU0477156797.USD","BAC","IE00BLSP4239.USD","BK4211","LU1880398471.USD","LU0320765489.SGD","LU0320765646.SGD","LU0321505439.SGD","LU0321505868.SGD","LU0149725797.USD","LU1496350171.SGD","LU1894683348.USD","BBNX","LU0306807586.USD","LU0683600562.USD","BK4585","LU0971096721.USD","IE00BZ1G4Q59.USD","SIVBQ","IE00BFXG1179.USD","LU0980610538.SGD","BK4504","LU1201861249.SGD","LU0053666078.USD","BK4553","BK4581"],"gpt_icon":1},{"id":"2513723314","title":"Beta Bionics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513723314?lang=en_us&edition=full_marsco","pubTime":"2025-02-24 20:28","pubTimestamp":1740400085,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF1FU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2513672371","title":"Beta Bionics Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2513672371","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513672371?lang=en_us&edition=full_marsco","pubTime":"2025-02-24 20:23","pubTimestamp":1740399780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2025 07:23 ET (12:23 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.betabionics.com","stockEarnings":[{"period":"1week","weight":-0.1361},{"period":"1month","weight":-0.3984},{"period":"3month","weight":-0.4288},{"period":"ytd","weight":-0.4288}],"compareEarnings":[{"period":"1week","weight":-0.115},{"period":"1month","weight":-0.1379},{"period":"3month","weight":-0.1578},{"period":"6month","weight":-0.1383},{"period":"1year","weight":-0.0429},{"period":"ytd","weight":-0.1529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Beta Bionics, Inc.","nameEN":"Beta Bionics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.2","shortVersion":"4.32.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beta Bionics, Inc.(BBNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Beta Bionics, Inc.(BBNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Beta Bionics, Inc.,BBNX,Beta Bionics, Inc.股票,Beta Bionics, Inc.股票老虎,Beta Bionics, Inc.股票老虎国际,Beta Bionics, Inc.行情,Beta Bionics, Inc.股票行情,Beta Bionics, Inc.股价,Beta Bionics, Inc.股市,Beta Bionics, Inc.股票价格,Beta Bionics, Inc.股票交易,Beta Bionics, Inc.股票购买,Beta Bionics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beta Bionics, Inc.(BBNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Beta Bionics, Inc.(BBNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}